![Steven Burke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Burke
Hoofd Techniek/Wetenschap/O&O bij
AKEBIA THERAPEUTICS, INC.
Vermogen: 502 783 $ op 31-08-2026
Profiel
Steven K.
Burke is currently Director at LeukoSight, Inc. and AbFero Pharmaceuticals, Inc. Since 2019, Dr. Burke has been Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. Formerly, Dr. Burke was Medical Director & VP-Clinical Research at GelTex Pharmaceuticals, Inc. from 1994 to 2001, Associate Director-Clinical Research at Glaxo, Inc., Senior VP-Medical and Regulatory Affairs at Genzyme Corp.
in 2011, Chief Medical Officer & Senior Vice President at Proteon Therapeutics, Inc. from 2006 to 2019, and Chief Medical Officer at Protara Therapeutics, Inc. Education includes a doctorate from Weill Cornell Medical College and undergraduate studies at Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 547.098 ( 0,2% ) | 502 783 $ | 31-08-2026 |
Actieve functies van Steven Burke
| Bedrijven | Functie | Begin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-06-2019 |
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Directeur/Bestuurslid | - |
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Directeur/Bestuurslid | - |
Eerdere bekende functies van Steven Burke
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
| PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Steven Burke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
